Vor Biopharma Inc. (VOR) Tops Q4 EPS by 7c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q4 EPS of ($0.53), $0.07 better than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• General Mills beats estimates as cost savings offset volumes
• Morgan Stanley refreshes Strait of Hormuz reopening analysis